About Us
Our Company
Leadership
Compliance
Contact
Medical Education Grants
Our
Medicines
YCANTH
Product
Candidates
Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications
Investors &
Media
Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection
Careers
Menu
About Us
Our Company
Leadership
Compliance
Contact
Medical Education Grants
Our
Medicines
YCANTH
Product
Candidates
Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications
Investors &
Media
Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection
Careers
For information about YCANTH® or to request a representative, visit YCANTHPro.com
Contact Us
For additional information on YCANTH
®
(cantharidin) topical solution 0.7% including how to request a representative visit or to obtain additional product information, please visit
YCANTHPro.com
Contact Form
Your name First/Last
Your email
Practice phone number
Regarding
- Select -
Business Development Inquiries
Medication Inquiries
General Inquiries
Medical Information and Clinical Research Inquiries
Practice ZIP Code
Medication
- Select -
YCANTH® (cantharidin)
Your message
Submit
Investor Contacts:
John Kirby
Interim Chief Financial Officer
info@verrica.com
Kevin Gardner
LifeSci Advisors
kgardner@lifesciadvisors.com
Chris Calabrese
LifeSci Advisors
ccalabrese@lifesciadvisors.com
Verrica
44 West Gay Street
Suite 400
West Chester, PA 19380
